SOURCE: Genomic Health, Inc.
March 09, 2011 08:00 ET
My Colon Blight Coach Is the Aboriginal Patient-Focused Interactive, Online Apparatus for Anew Diagnosed Colon Blight Patients
REDWOOD CITY, CA–(Marketwire – March 9, 2011) – Genomic Health, Inc. (NASDAQ: GHDX), in affiliation with Fight Colorectal Cancer, today alien My Colon Blight Coach, a different online apparatus that provides patients with a personalized abode of their specific blazon of colon cancer. Coach empowers patients with abundant advice based on a cardinal of key analytic questions to appoint in a added a chat and an alive role with their healthcare team.
Coach launched today at Fight Colorectal Cancer’s Call-on Congress accident in Washington, D.C., and is accessible on Fight Colorectal Cancer’s website and at www.mycoloncancercoach.org. The Coach apparatus is anecdotal by Richard M. Goldberg, MD, Distinguished Professor of Gastrointestinal Blight Analysis and Associate Director for Analytic Analysis at the University of North Carolina’s Lineberger Comprehensive Blight Center, who is on the Medical Advisory Board of Fight Colorectal Blight and is a advance with the organization. Coach walks patients through a simple check with audio advice to advice them bigger accept key colon blight agreement and important advice about their diagnosis. Based on advice provided by the patient, Coach creates a customized abode for patients to allotment with their doctor as they altercate assay options.
“The aboriginal few weeks afterward a colon blight assay can be cutting for a patient, abnormally back there is so abundant advice to assay through,” said Carlea Bauman, President of Fight Colorectal Cancer. “Fight Colorectal Blight was admiring to advice actualize My Colon Blight Coach because it helps patients get important advice that addresses their specific diagnosis.”
My Colon Blight Coach includes a host of important resources, including advice on bump testing and assay options, which are advised to abode the questions and apropos of anew diagnosed patients. The ambition of the ability is to animate patients to accept accomplished conversations with their doctors, ultimately arch to added personalized, tailored treatment.
“Genomic Health is committed to allowance physicians and patients enhance the affection of assay decisions through the abundant genomic assay of a patient’s bump tissue,” said Kim Popovits, President and CEO of Genomic Health. “My Colon Blight Coach was advised to advice patients bigger accept their assay and assay options with the ambition of facilitating added allusive discussions with their doctors.”
My Colon Blight Coach joins My Breast Blight Coach, an online accommodating ability for anew diagnosed blight patients offered by Breastcancer.org and Genomic Health. Both accoutrement advice patients with blight apprentice added about their assay and accommodate them with advice so they can booty an alive role in authoritative decisions about their treatment.
About Genomic Health, Inc.
Genomic Health, Inc. (NASDAQ: GHDX) is a atomic affection aggregation focused on the all-around development and commercialization of genomic-based analytic class casework that assay the basal analysis of blight acceptance physicians and patients to accomplish abundant assay decisions. Its advance product, the Oncotype DX® blight test, has been apparent to adumbrate the likelihood of chemotherapy account as able-bodied as ceremony in early-stage cancer. In accession to this broadly adopted test, Genomic Health provides the Oncotype DX colon blight test, the aboriginal multigene announcement analysis developed for the appraisal of accident of ceremony in patients with date II disease. As of December 31, 2010, added than 10,000 physicians in over 60 countries had ordered added than 190,000 Oncotype DX tests. Genomic Health has a able-bodied activity focused on developing tests to optimize the assay of prostate and renal corpuscle cancers, as able-bodied as added stages of and colon cancers. The aggregation is based in Redwood City, California with European address in Geneva, Switzerland. For added information, amuse appointment www.genomichealth.com.
About Fight Colorectal Blight
Fight Colorectal Blight demands a cure for colon and abdominal cancer. We brainwash and abutment patients, advance for changes in action that will access and advance research, and empower survivors to accession their choir adjoin the cachet quo.
This columnist absolution contains advanced statements aural the acceptation of the Private Securities Litigation Reform Act of 1995, including statements apropos to the company’s expectations of the amount and account to physicians, patients and payors of its colon blight test, the company’s expectations as to the analytic account of its colon blight analysis for patients with date II colon cancer, the acceptance that our above-mentioned development and commercialization action can be activated to a analysis for colon cancer, the reproducibility of antecedent abstraction results, the timing and success of the company’s affairs to barrage a analysis for conflict adjustment status, the account of analytic abstraction after-effects to absolute outcomes, our behavior apropos the prerequisites all-important to advance a analysis for colon cancer, and our expectations apropos approaching advance of the company’s business. Advanced statements are accountable to risks and uncertainties that could account absolute after-effects to alter materially, and appear after-effects should not be advised as an adumbration of approaching performance. These risks and uncertainties include, but are not bound to: the risks and uncertainties associated with the adjustment of the company’s tests; the appulse of competition, the after-effects of analytic studies; the account of analytic abstraction after-effects to absolute outcomes; and the added risks set alternating in the company’s filings with the Securities and Exchange Commission, including the risks set alternating in the company’s Quarterly Abode on Form 10-Q for the division concluded September 30, 2010. These advanced statements allege alone as of the date hereof. Genomic Health disclaims any obligation to amend these advanced statements.
NOTE: The Genomic Health logo, Oncotype, Oncotype DX and Ceremony Score are trademarks or registered trademarks of Genomic Health, Inc. All added trademarks and account marks are the acreage of their corresponding owners.
Five Things You Didn’t Know About Coach Repair Service Request Form | Coach Repair Service Request Form – coach repair service request form
| Encouraged to help my personal blog, on this time period I will show you regarding coach repair service request form